ARCHIVES

GAO Backs DeVita On Why advances Aren’t Producing Mortality Reduction

This article is from The Cancer Letter archive.

Vol. 14 No. 06 | February 5, 1988

Download PDF Visit The Full Archive

Related Articles

In Brief: House, Senate Authorization Measuring Waiting Floor Action; Money Bill Markups Pending

June 13, 1980

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012

President Accepts Compromise On HEW Money Bill; Cancer Gets $523.6 Million

December 21, 1973

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

July 9, 2010

Who Writes NCI’s bypass Budget anyway>? Editor’s name Revealed

May 14, 1993

Banned Investigator Plans To Resume Clinical Trials Role

August 10, 1990